Literature DB >> 12836901

Application of the combined quality improvement ratio in the evaluation of a quality improvement activity in a managed care organization.

Marie A Krousel-Wood1, Richard B Chambers, Richard N Re, Phyllis R Nitzkin, Laurence M Cortez.   

Abstract

Assessing the impact of clinically relevant quality improvement activities (QIA) is important to managed care organizations; yet, turnover in enrollment can reduce the data available for analyses, thus decreasing the chance that a difference post-QIA will be detected. The Combined Quality Improvement Ratio (CQuIR) uses matching of patients into pairs pre- and post-QIA to systematically and validly increase the data included in the analysis for evaluation of the QIA. Using a paired cohort study design, 456 pairs of patients with diabetes were identified using the Health Plan Employer Data Information Set (HEDIS) specifications. Patients having retinal examinations were identified pre- and post-QIA. The change in retinal examination rates was analyzed and results compared using repeated pairs (RP), matched pairs (MP), and combined pairs (CP). The CQuIR methodology (which uses CP = RP + MP) resulted in an increase in sample size (n = 456 [CP] versus n = 156 [RP] and n = 300 [MP]) and consequently an increase in power (0.92 [CP] versus 0.38 [RP] and 0.82 [MP]) and a decrease in the confidence interval range (0.97 [CP] versus 2.06 [RP] and 1.14 [MP]). The CQuIR uses a statistically valid approach to increase the data available for the evaluation of QIAs.

Entities:  

Mesh:

Year:  2003        PMID: 12836901     DOI: 10.1177/106286060301800305

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  2 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

2.  Clinicians' guide to statistics for medical practice and research: part I.

Authors:  Marie A Krousel-Wood; Richard B Chambers; Paul Muntner
Journal:  Ochsner J       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.